Search research articles
Contact Us
Filters
Showing results (141-150 of 420) with videos related to
Page
of 42
Sort By:
Antimicrobial Agents and Chemotherapy
|
February 1, 1987
In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin
A L Barry, C Thornsberry, R N Jones
Journal of Clinical Microbiology
|
January 1, 1986
Evaluation of teicoplanin and vancomycin disk susceptibility tests
A L Barry, C Thornsberry, R N Jones
Antimicrobial Agents and Chemotherapy
|
April 1, 1989
Antibacterial activity of trospectomycin (U-63366F) and initial evaluations of disk diffusion susceptibility tests
A L Barry, R N Jones, C Thornsberry
Journal of Clinical Microbiology
|
August 1, 1983
Proposed zone standards for interpretation of fortimicin A disk diffusion tests
A L Barry, C Thornsberry, R N Jones
Journal of Clinical Microbiology
|
March 1, 1985
Feasibility study of disk diffusion susceptibility tests with Mueller-Hinton broth solidified with Gelrite, an agar substitute
A L Barry, L Creitz, R R Packer
The Journal of Antimicrobial Chemotherapy
|
March 1, 1989
In-vitro activity of the penem, FCE 22101, and tentative interpretive criteria for disc susceptibility tests
A L Barry, R N Jones, C Thornsberry
Journal of Clinical Microbiology
|
July 1, 1983
Disk agar diffusion susceptibility testing with 30-micrograms ceftazidime disks: confirmation of interpretive breakpoints and quality control guidelines
R N Jones, A L Barry, C Thornsberry
Antimicrobial Agents and Chemotherapy
|
January 1, 1986
In vitro evaluation of A-56619 and A-56620, two new quinolones
A L Barry, C Thornsberry, R N Jones
Antimicrobial Agents and Chemotherapy
|
June 1, 1984
In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin
R N Jones, C Thornsberry, A L Barry
Journal of Clinical Microbiology
|
February 1, 1983
Evaluation of the cefonicid disk test criteria, including disk quality control guidelines
A L Barry, R N Jones, C Thornsberry
Page
of 42
Search research articles
Search
Showing results (141-150 of 420) with videos related to
Sort By:
Page
of 42
Antimicrobial Agents and Chemotherapy
|
February 1, 1987
In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin
A L Barry, C Thornsberry, R N Jones
Journal of Clinical Microbiology
|
January 1, 1986
Evaluation of teicoplanin and vancomycin disk susceptibility tests
A L Barry, C Thornsberry, R N Jones
Antimicrobial Agents and Chemotherapy
|
April 1, 1989
Antibacterial activity of trospectomycin (U-63366F) and initial evaluations of disk diffusion susceptibility tests
A L Barry, R N Jones, C Thornsberry
Journal of Clinical Microbiology
|
August 1, 1983
Proposed zone standards for interpretation of fortimicin A disk diffusion tests
A L Barry, C Thornsberry, R N Jones
Journal of Clinical Microbiology
|
March 1, 1985
Feasibility study of disk diffusion susceptibility tests with Mueller-Hinton broth solidified with Gelrite, an agar substitute
A L Barry, L Creitz, R R Packer
The Journal of Antimicrobial Chemotherapy
|
March 1, 1989
In-vitro activity of the penem, FCE 22101, and tentative interpretive criteria for disc susceptibility tests
A L Barry, R N Jones, C Thornsberry
Journal of Clinical Microbiology
|
July 1, 1983
Disk agar diffusion susceptibility testing with 30-micrograms ceftazidime disks: confirmation of interpretive breakpoints and quality control guidelines
R N Jones, A L Barry, C Thornsberry
Antimicrobial Agents and Chemotherapy
|
January 1, 1986
In vitro evaluation of A-56619 and A-56620, two new quinolones
A L Barry, C Thornsberry, R N Jones
Antimicrobial Agents and Chemotherapy
|
June 1, 1984
In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin
R N Jones, C Thornsberry, A L Barry
Journal of Clinical Microbiology
|
February 1, 1983
Evaluation of the cefonicid disk test criteria, including disk quality control guidelines
A L Barry, R N Jones, C Thornsberry
Page
of 42